{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:39:54Z","timestamp":1758044394438,"version":"3.44.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["R1046"],"award-info":[{"award-number":["R1046"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.retram.2025.103517","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:08:57Z","timestamp":1745899737000},"page":"103517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insights"],"prefix":"10.1016","volume":"73","author":[{"given":"Changchang","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojian","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-8206","authenticated-orcid":false,"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.retram.2025.103517_bib0001","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/infdis\/jiz454","article-title":"Cytomegalovirus infection in solid organ and hematopoietic cell transplantation: state of the evidence","volume":"221","author":"Haidar","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.retram.2025.103517_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228451","article-title":"Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - a single center 11-year analysis","volume":"15","author":"D\u00fcver","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.retram.2025.103517_bib0003","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00277-020-04201-4","article-title":"Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation","volume":"99","author":"Meng","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.retram.2025.103517_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2024.102039","article-title":"Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: insights from a real-world experience","volume":"84","author":"McGuirk","year":"2024","journal-title":"Transpl Immunol"},{"issue":"9","key":"10.1016\/j.retram.2025.103517_bib0005","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.15515","article-title":"Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): a systematic review, meta-analysis, and meta-regression analysis","volume":"19","author":"Gim\u00e9nez","year":"2019","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.retram.2025.103517_bib0006","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/cid\/ciz1210","article-title":"Cytomegalovirus (CMV) cell-mediated immunity and CMV infection after allogeneic hematopoietic cell transplantation: the REACT study","volume":"71","author":"Chemaly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.retram.2025.103517_bib0007","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.retram.2025.103517_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106860","article-title":"Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants","volume":"62","author":"Allaw","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0009","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2024.065","article-title":"Update on cytomegalovirus infection management in allogeneic hematopoietic stem cell transplant recipients. A consensus document of the Spanish group for hematopoietic transplantation and cell therapy (GETH-TC)","volume":"16","author":"Pi\u00f1ana","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"16","key":"10.1016\/j.retram.2025.103517_bib0010","doi-asserted-by":"crossref","first-page":"8728","DOI":"10.3390\/ijms22168728","article-title":"Immune prophylaxis and therapy for human cytomegalovirus infection","volume":"22","author":"Struble","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007735","article-title":"Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation","volume":"12","author":"Ma","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.retram.2025.103517_bib0012","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1002\/hsr2.322","article-title":"Immunotherapy with adoptive cytomegalovirus-specific T cells transfer: summarizing latest gene engineering techniques","volume":"4","author":"Mehdizadeh","year":"2021","journal-title":"Health Sci Rep"},{"issue":"4","key":"10.1016\/j.retram.2025.103517_bib0013","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41423-021-00829-y","article-title":"Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation","volume":"19","author":"Pei","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"10.1016\/j.retram.2025.103517_bib0014","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1172\/JCI90599","article-title":"Immunotherapy for transplantation-associated viral infections","volume":"127","author":"Roddie","year":"2017","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.retram.2025.103517_bib0015","first-page":"120","article-title":"Adverse effects of virus-specific T-Cell therapy: an integrative review","volume":"10","author":"Simmons","year":"2019","journal-title":"J Adv Pract Oncol"},{"issue":"10","key":"10.1016\/j.retram.2025.103517_bib0016","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.retram.2025.103517_bib0017","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2025.103517_bib0018","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1172\/JCI90599","article-title":"Immunotherapy for transplantation-associated viral infections","volume":"127","author":"Roddie","year":"2017","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","article-title":"Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation","volume":"12","author":"Kaeuferle","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10.1016\/j.retram.2025.103517_bib0020","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.V97.4.994","article-title":"Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions","volume":"97","author":"Peggs","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2025.103517_bib0021","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jix357","article-title":"Cytomegalovirus-specific T-cell transfer for refractory cytomegalovirus infection after haploidentical stem cell transplantation: the quantitative and qualitative immune recovery for cytomegalovirus","volume":"216","author":"Pei","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.retram.2025.103517_bib0022","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2249.2005.02914.x","article-title":"Optimum in vitro expansion of human antigen-specific CD8+ T cells for adoptive transfer therapy","volume":"142","author":"Montes","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"17","key":"10.1016\/j.retram.2025.103517_bib0023","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/bloodadvances.2019000371","article-title":"Mini\u201d bank of only 8 donors supplies CMV-directed T cells to diverse recipients","volume":"3","author":"Tzannou","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.retram.2025.103517_bib0024","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165476","article-title":"Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant","volume":"133","author":"Prockop","year":"2023","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.retram.2025.103517_bib0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.exphem.2003.12.009","article-title":"Isolation and expansion of human adenovirus\u2013specific CD4 and CD8 T cells according to IFN-\u03b3 secretion for adjuvant immunotherapy","volume":"32","author":"Feuchtinger","year":"2004","journal-title":"Exp Hematol"},{"issue":"11","key":"10.1016\/j.retram.2025.103517_bib0026","first-page":"1371","article-title":"Recombinant MHC tetramers for isolation of virus-specific CD8+ cells from healthy donors: potential approach for cell therapy of posttransplant cytomegalovirus infection","volume":"81","author":"Vdovin","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.retram.2025.103517_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.988947","article-title":"Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure","volume":"14","author":"Tischer-Zimmermann","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcyt.2020.08.006","article-title":"Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay","volume":"23","author":"Lazarski","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.retram.2025.103517_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108456","article-title":"Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21","volume":"217","author":"Luo","year":"2020","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.retram.2025.103517_bib0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcyt.2023.02.003","article-title":"Cost-effective strategy for selection of third-party donors for a virus-specific T-cell bank for an Asian patient population","volume":"25","author":"Linn","year":"2023","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.retram.2025.103517_bib0031","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fimmu.2020.00271","article-title":"Characterization of a cytomegalovirus-specific T lymphocyte product obtained through a rapid and scalable production process for use in adoptive immunotherapy","volume":"25","author":"Grau-Vorster","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.retram.2025.103517_bib0032","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.2022016202","article-title":"Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies","volume":"141","author":"Quach","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2025.103517_bib0033","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)\u2013specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0034","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jcyt.2013.07.008","article-title":"Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy","volume":"16","author":"Wang","year":"2014","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.retram.2025.103517_bib0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients","volume":"26","author":"Dudley","year":"2003","journal-title":"J Immunother"},{"issue":"14","key":"10.1016\/j.retram.2025.103517_bib0036","article-title":"IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation","volume":"20","author":"Lee","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0037","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2005.11.003","article-title":"Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3\/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy","volume":"119","author":"Chen","year":"2006","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.retram.2025.103517_bib0038","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ymthe.2020.06.002","article-title":"CRISPR-Cas9-mediated glucocorticoid resistance in virus-specific T cells for adoptive T cell therapy post transplantation","volume":"28","author":"Kaeuferle","year":"2020","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0039","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/CJI.0000000000000105","article-title":"Adenovirus-specific T-cell subsets in human peripheral blood and after IFN-g immunomagnetic selection","volume":"39","author":"Qian","year":"2016","journal-title":"J Immunother"},{"issue":"31","key":"10.1016\/j.retram.2025.103517_bib0040","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.retram.2025.103517_bib0041","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.bbmt.2018.08.024","article-title":"Establishment and operation of a third-party virus-specific T cell bank within an allogeneic stem cell transplant program","volume":"24","author":"Micklethwaite","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.retram.2025.103517_bib0042","article-title":"Comprehensive analysis of CD4+ T cell responses to CMV pp65 antigen restricted by single HLA-DR, -DQ, and -DP allotype within an individual","volume":"15","author":"Hyun","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.retram.2025.103517_bib0043","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2017.01591","article-title":"Comprehensive analysis of cytomegalovirus pp65 antigen-specific CD8+ T cell responses according to human leukocyte antigen class I allotypes and intra individual dominance","volume":"21","author":"Hyun","year":"2017","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.retram.2025.103517_bib0044","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2014-06-573725","article-title":"Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT","volume":"125","author":"Feucht","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2025.103517_bib0045","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.4110\/in.2023.23.e41","article-title":"The role of CD4 T cell help in CD8 T cell differentiation and function during chronic infection and cancer","volume":"23","author":"Topchyan","year":"2023","journal-title":"Immune Netw"},{"issue":"6925","key":"10.1016\/j.retram.2025.103517_bib0046","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"21","author":"Janssen","year":"2003","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.retram.2025.103517_bib0047","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1182\/bloodadvances.2022007005","article-title":"Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy","volume":"6","author":"Hasan","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0048","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1038\/s41467-024-47057-2","article-title":"Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment","volume":"15","author":"Keller","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.retram.2025.103517_bib0049","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/vaccines8030402","article-title":"Revisiting CD8 T-cell 'memory inflation': new insights with implications for cytomegaloviruses as vaccine vectors","volume":"8","author":"Holtappels","year":"2020","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.retram.2025.103517_bib0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.immuni.2018.03.015","article-title":"KLRG1+ Effector CD8+ T cells lose KLRG1, differentiate into all memory T cell lineages, and convey enhanced protective immunity","volume":"48","author":"Herndler-Brandstetter","year":"2018","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.retram.2025.103517_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108501","article-title":"CD57+ memory T cells proliferate in vivo","volume":"33","author":"Ahmed","year":"2020","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.retram.2025.103517_bib0052","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fimmu.2017.00854","article-title":"Influence of irradiated peripheral blood mononuclear cells on both ex vivo proliferation of human natural killer cells and change in cellular property","volume":"24","author":"Delso-Vallejo","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0053","article-title":"Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors","volume":"5","author":"Jin","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"10.1016\/j.retram.2025.103517_bib0054","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1081\/IMM-120030732","article-title":"The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes","volume":"33","author":"Benczik","year":"2004","journal-title":"Immunol Invest"},{"issue":"25\u201326","key":"10.1016\/j.retram.2025.103517_bib0055","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1016\/j.vaccine.2003.07.022","article-title":"IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques","volume":"22","author":"Villinger","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.retram.2025.103517_bib0056","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2012-05-431718","article-title":"IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors","volume":"121","author":"Cieri","year":"2013","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.retram.2025.103517_bib0057","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.omtm.2022.04.013","article-title":"Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products","volume":"9","author":"Durkee-Shock","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"9","key":"10.1016\/j.retram.2025.103517_bib0058","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41590-020-0733-2","article-title":"Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.retram.2025.103517_bib0059","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41467-019-11280-z","article-title":"Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1","volume":"10","author":"Leclerc","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.retram.2025.103517_bib0060","doi-asserted-by":"crossref","first-page":"e1149","DOI":"10.1002\/cti2.1149","article-title":"Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells","volume":"9","author":"McGuire","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.retram.2025.103517_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.779961","article-title":"Dissecting the landscape of activated CMV-stimulated CD4+ T cells in humans by linking single-cell RNA-Seq with T-cell receptor sequencing","volume":"12","author":"Lyu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2025.103517_bib0062","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2020.01859","article-title":"Transcriptional profiling of CD8+ CMV-specific T cell functional subsets obtained using a modified method for isolating high-quality RNA from fixed and permeabilized cells","volume":"11","author":"Healy","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.retram.2025.103517_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113250","article-title":"In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction","volume":"42","author":"Schmidt","year":"2023","journal-title":"Cell Rep"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:15:37Z","timestamp":1757679337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2452318625000261"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103517","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insights","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103517"}}